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Abstract 
We have investigated the properties of a two-sample sequential rank test proposed 
by Sen (1981) by means of stochastic simulation. The test is claimed to be non-
parametric. Our simulations show that the significance level and power are not 
far from the respective nominal values for most of the selected distributions. How-
ever, the simulated values deviate significantly from the nominal values for some 
distributions. Compared to another two-sample sequential rank test proposed by 
Skovlund and Wall(l)e (1988), Sen's test reaches a decision somewhat earlier, but 
the significance level and power are more dependent on the shape of the distribu-
tions of observations, and the test statistic is much more cumbersome to calculate. 
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t. 
1. INTRODUCTION 
Skovlund and Wall!11e (1988) have recently developed a sequential two-sample rank 
test by means of stochastic simulation. The test is based on the Wilcoxon-Mann-
Whitney two-sample test for fixed sample sizes and has been shown to be robust 
and approximately distribution free. It has been suggested to the authors that 
possibly a better distribution free sequential two-sample test could be developed 
from the TypeD test suggested by Sen (1981, p. 255). The present paper describes 
the development and exploration of such a test. 
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2. THEORY 
Following Sen (1981; pp 255, 264) let {Xi,i ~ 1} be a sequence of independent 
observations and we assume that 
where the ci are known constants, 0 or 1, and the ci are independent identically 
distributed random variables with density f(t). The problem is to test H0 : ~ = 0 
versus H 1 : ~ = .6.1(> 0). In the frame of sequential clinical trials the Xi are the 
responses of the patients either in the treatment group ( Ci = 1) or in the control 
group ( Ci = 0). Under H 0 the responses in both groups have the same distribution, 
i.e. the treatment has no effect. 
We observe the Xi sequentially. Let m be the number of observations in the 
treatment group among then first observations and let Wn be Wilcoxon's rank-
sum statistic. The statistic 
Un = (Wn- m(n + 1)/2)/( vm(n- m)(n + 1)) 
has mean 0 and variance 1/12(n+1) under H 0 and under alternative ~1 close to 
0 the asymptotic mean of Un is tJ..1'Y(f) if m/n---+- p where 
+oo 
!(!) = VP(1- p). J f 2(t)dt = t/>(p). K(j) 
-oo 
If b is subtracted from all the observations in the treatment group before W n is 
calculated, we denote the new statistics Wn(b) and Un(b) respectively. 
Sen suggests basing a sequential test on 
1 
Zn = ~1DnUn(2~1)12(n + 1) 
where {Dn} is a consistent sequence of estimators of 'Y(f). (If 'Y(f) is known, 'Y(f) 
may replace Dn in Zn.) Starting with an initial sample of size no, proceed as usual 
in sequential probability ratio tests until one of the inequalities 
In _/3_ = b < Zn < a = ln 1 - f3 
1-a a 
is violated. Let M be the first n such that ZM ft (b, a}, then accept Ho if ZM :5 b 
and accept H1 if ZM ~a. Here a is the nominal significance level and 1- f3 is the 
nominal power. 
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We now return to the construction of a consistent sequence of estimators of 
'Y(f). A consistent sequence of estimators of ¢J(p) = .Jp(1 - p) is obviously 
¢J( ';:) = .J': (1 - ';: ), and consistent sequences of estimators of the integral K(j) = 
+(X) J f 2(t)dt are found on p. 264 in Sen. In our case we base our sequence on 
-(X) 
Wilcoxon's rank-sum statistic and utilize the close connection between this statis-
tic and all differences between the observations in the treatment group and in the 
control group. Let D(l) < D(2) < · · · < D(m(n-m)) be these differences ordered, 
then (see Lehmann (1975; Theorem 4, p. 87)) 
1 
D(l) < Ll '¢:=:::} Wn(A):::; m(n- m) + 2m(m + 1) -1. 
This leads after some calculation to the following estimator of K.(j) 
where 
n 2 -1 
12 
1 1 
n';:(l- ';:) n + 1 
12 - 1 } m( n - m) ± . J n2 - 1 m ( m) 
= uf/2 n- 1--l1 2 12 n n 
and uf/2 is the upper ~-fractile of the N(O, I)-distribution. 
This has all been developed under the assumption that the Ci are fixed. However, 
we consider the Ci as independent identically random variables with P( Ci = 1) = 
p = 1- P(ci = 0), and we examine the behaviour of Sen's test in case p = 1/2. 
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3. SIMULATION 
To examine the properties of Sen's test, we have used computer simulation. The 
simulation programs were written in the programming language SIMULA (Birtwistle 
et al, 1983). The pseudo-random number generator in SIMULA is a multiplicative 
congruential generator (Bratley et al, 1983). The simulations were performed on 
a DEC 2060/2065 computer at the University of Oslo. 
We are especially interested in modelling sequential clinical trials, and have there-
fore restricted our simulations to differences in treatment effect which are usually 
clinically relevant. The simulations have therefore been performed for differences 
ranging froin ~ = 0.5 to d = 2 in distributions with standard deviation 1. In 
the simulation model the response for each patient is supposed to be known be-
fore a new patient is included. Each included patient is randomized either to a 
treatment group or to a control group with probability p = 1/2. After randomiza-
tion a response is drawn from a given distribution. Under the null hypothesis (no 
treatment difference) the responses are drawn from the same distribution. Under 
the alternative hypothesis the respc;mses in the two groups are drawn from similar 
distributions with equal variances but different expectations. 
Based on the responses of the patients included in the trial so far (at least one in 
each group), the test statistic is calculated. If neither of the boundaries is crossed, 
a new patient is included, and the test statistic is again calculated. When one of 
the boundaries is crossed, the result (acceptance or rejection of the null hypothesis) 
and the m.unber of patients used is registered. One such sequence is repeated N 
times. 
In a non-parametric situation the value of K,(f) = J P(t)dt has to be estimated, 
but if the distribution is known, the exact value may be used. For the normal, 
uniform, logistic and double exponential distributions we have calculated K,(f) 
when u2 = 1. The alternative 6. is expressed in units of the standard deviation. 
The Cauchy distribution f( x) = r / ( 1r( r 2 + x 2 )) has no variance. To obtain the 
same probability between -1 and +1 as for the standard normal distribution, the 
parameter r = 0.54427 is chosen. 
The estimation of K,(f) is described at the end of the previous section. The esti-
mation starts when a chosen number of patients no has been included in the trial. 
We have used e = 0.05. 
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4. RESULTS 
In the test statistic Zn we use either Dn = <P( ';: )K(j) or Dn = <P( ';: )Kn. In the 
first case the calculation of Zn is started when at least one patient is included 
in each group. In the second case the calculation starts when no patients are 
included. 
First we have examined the properties of the test in the situation where the dis-
tribution is known. Here K(f) was calculated for the normal, uniform, double 
exponential, logistic and Cauchy distributions. Hence, this version of the test is 
not supposed to be distribution free. In Table 1, the simulated significance level 
and power of Sen's test are shown together with K(j) for each chosen type of dis-
tribution. The nominal values of the significance level and power are a = 0.05 
and 1- {3 = 0.95. The alternative hypothesis is 6. = 1. Each result is based on 
N = 10000 simulations. The results are close to the nominal values except for 
the uniform and the Cauchy distribution where the significance level is a little 
too large and the power a little too small. Similar results were obtained for other 
choices of a and 1 - {3. 
We next examined how the choice of number of initial observations no influenced 
the significance level and the power when K(f) was estimated. Table 2 shows 
this as well as the mean and median number of patients included before the trial 
is stopped, and the mean and median of Dn = <P( ';:) • Kn. The responses are 
drawn from normal distributions, and the alternative is 6. = 1. For small values 
of n0 the simulated significance level and power deviate substantially from the 
nominal values 0.05 and 0.95. The estimates Dn also deviate from the calculated 
value -y(J) = 1/( 4y'7r) = 0.141. Only when no = 10 or n 0 = 12, are the results 
satisfactory. For larger values of n0 , the test becomes too conservative, as the 
number of patients included becomes larger than actually necessary. For values 
of no of about 30, the procedure will no longer be sequential, because the trial 
is stopped when exactly no patients are included. Based on the results shown in 
Table 2, we have chosen to use n0 = 10 for further investigation of the properties 
of the test. 
We have also compared the simulation results from the two types of situations 
(i) distribution known and thus K(j) calculated and (ii) distribution unknown 
and thus K(f) estimated by Kn· Such comparisons are shown in Tables 3 and 
4. In Table 3, the significance level and power of the test using K(j) and K n are 
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compared when the responses are drawn from normal distributions where ~ is 
the alternative. The last column of Table 3 gives Dn = </>( '::) • Kn which is the 
estimates of the exact value 7(!) = 1/(4Vi) = 0.141. For small values of~' the 
simulated significance level and power and Dn are satisfactory. For larger values 
of ~' the test becomes too conservative, especially when K.{f) is estimated. 
Table 4 shows the robustness properties of the test. In the first part of the table, 
K.{/) is calculated for the normal distribution even when the responses come from 
other distributions, e.g. contaminated normal or skew distributions. The nominal 
significance level and power are again a = 0.05 and 1- {3 = 0.95, and ~ = 1. 
The test seems to be quite robust, but not distribution free. The other part of 
the table shows the results of the test when K.(/) is estimated by Kn· As far as 
contaminated normal distributions a.re concerned, this procedure is more robust, 
but even if the results are slightly improved also for the other distributions, they 
still deviate quite substantially from the nominal values. 
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5. DISCUSSION 
The development of Sen's TypeD test assumes among other things small values of 
the treatment difference .6.. However, in clinical trials the discovery of very small 
treatment differences is often not of interest. Trials including large numbers of 
patients are also difficult to handle. We have therefore restricted our simulations 
to~ 2 0.5. 
The test has been developed under the assumption that the Ci are fixed. Our 
simulations have been performed both with fixed Ci and with Ci as random variables 
where P(ci = 1) = P(ci = 0) = 1/2. The results were more or less identical, and 
we have chosen to present the results of random Ci which is the more common 
situation in clinical trials. 
When calculating or estimating the value of 1(!), we have presented the results 
of simulations based on 1Cf) = ¢>( ';:) · K(j) where m is the number of patients 
included in the treatment group and n is the total number of patients included. 
Another possibility would have been to put ¢>(p) = 1/2 inste8;d of the estimate 
¢>( ';: ). Then 1(!) = !K(f). As m/n ~ 1/2 throughout the trial, there is hardly 
any difference between using ¢>(p) and ¢>( ';:) for small values of .6.. When .6. is large, 
however, only few patients are included, and m/n will often deviate substantially 
from 1/2. A small simulation study comparing the two alternatives has confirmed 
that the results are slightly better when using ¢>( ';;) than when using ¢>(p) = 1/2. 
The number of patients n 0 included before starting the estimation of 1(!) is of 
importance to the test result. If a small n 0 is chosen, the estimates deviate sub-
stantially from the theoretical values, and the significance level and power of the 
test become too large and too small, respectively. For large values of no the test 
becomes too conservative. We have found the value n 0 = 10 to be satisfactory for 
our range of .6.. The estimates of 1Cf) are then close to the theoretical values, and 
the significance level and power are close to the respective nominal values when 
.6. < 1.25. The reason that the test becomes too conservative when .6. > 1.25 is 
that the choice of n 0 = 10 results in inclusion of more patients than would actually 
have been necessary to reach a conclusion if K(f) had been calculated. The choice 
of a smaller no could reduce this problem, but then the estimate Kn would deviate 
even more from K(j) and the test would not be exact anyway. Hence, K(f) should 
probably not be estimated when A > 1.25. 
For the normal distribution N(O, 1), K(/) = 1/(2Vi). Using tlus value even when 
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the observations are not normal, shows that this version of the test is actually 
quite robust. When "'(!) is estimated instead, the test is slightly more robust, 
especially when the observations come from contaminated normal distributions. 
The difference is slight, however, and even when the estimation method is used, 
the test is dependent on the shape of the distributions. 
In addition to investigating the properties of the type D test, we have examined 
the type C test (Sen, 1981, p. 254). The properties of the type C test have been 
examined in the same manner as the typeD test. A comparison of the two tests 
shows that the type C test is even more conservative than the type D test, it is less 
robust and definitely not distribution free. Even when the exact value of "'(!) is 
calculated, the real values of the significance level and power deviate substantially 
from the nominal values. Undoubtedly the typeD test is a better alternative than 
the type C test. 
Sen's typeD test has been investigated as alternative to the test by Skovlund and 
Wall0e (1988). One of the advantages of Sen's test is that it includes a smaller 
number of patients to reach a conclusion. If the alternative is ~ = 1 and the 
.. . 
observations are N(O, 1) under Ho, Skovlund and Wall0e's test needs 22 patients 
(median) under Ho and 29 under H 1 , while Sen's test needs 22 patients both 
under H 0 and under H 1 . The robustness properties of the two tests are not very 
different; for both tests the simulated power is close to the nominal value over 
a range of distributions. There is however a tendency towards Sen's test being 
a little more robust as far as contaminated normal distributions are concerned. 
On the other hand the simulated significance level is much closer to the nominal 
value for Skovlund and Wall0e's test than for Sen's test where it tends to be too 
small, even when"'(!) is estimated. Contrary to the test by Skovlund and Wall0e, 
Sen's test seems not to be distribution free. If"'(!) is estimated, Sen's test is also 
much more cumbersome to use. Despite the theoretical basis of Sen's test, the 
test by Skovlund and Wall0e therefore seems to be more useful for most practical 
situations when ~ ~ 0.5. 
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Distribution IC(f) a 1-/J 
Normal (0,1) 1/(2..,fi) 0.0453 0.9503 
Uniform (O,v'I2) 1/ffi 0.0610 0.9395 
Double exp (A = ../2) ../2/4 0.0481 0.9497 
Logistic (b = VJ/1r) 7r/(6VJ) 0.0466 0.9527 
Cauchy (r = 0.54427) 1/(6r) 0.0600 0.9426 
Table 1. 
Simulated values of the significance level and power when the distribution is known and thus the 
exact value of K(f) can be calculated. The nominal significance level is 0.05 and the nominal power 
is 0.95. The alternative hypothesis is a= 1. Behind each result lie N = 10000 simulations. 
f, 
no & #pats. Dn 1-/3 #pats. Dn 
mean mean mean mean 
median median median median 
3 0.165 16.4 1.623 0.831 16.9 1.194 
10.0 0.172 11.0 0.170 
5 0.076 23.3 0.174 0.901 23.8 0.177 
19.0 0.139 19.0 0.140 
8 0.070 25.0 0.144 0.924 26.8 0.144 
21.0 0.136 21.0 0.136 
10 0.056 25.7 0.142 0.925 26.9 0.142 
21.0 0.135 22.0 0.134 
12 0.051 26.4 0.141 0.938 27.9 0.139 
22.0 0.135 22.0 0.133 
15 0.043 28.1 0.139 0.945 29.3 0.139 
22.0 0.135 23.0 0.133 
18 0.037 29.4 0.138 0.956 31.1 0.136 
23.0 0.133 24.0 0.132 
20 0.037 30.0 0.137 0.959 32.3 0.136 
24.0 0.133 26.0 0.132 
Table 2 
Simulated values of the significance level and power for different values of n 0 . The nominal values 
are a= 0.05 and 1- f3 = 0.95. Here no is the number of patients included before the estimation 
of '"Y(/) is started. The mean and median number of patients included and the mean and median 
of Dn are also shown. The theoretical value of '"Y(/) is 0.141. Behind each result lie N = 1000 
simulations. The responses are drawn from normal distributions with rr = 1, and the alternative 
is .6. = 1. 
K{f) K,. 
& #pats 1-p #pats & #pats 1-p #pats D,. 
mean mean mean mean mean 
median median median median median 
0.5 0.0488 93.4 0.9539 94.8 0.068 90.4 0.952 92.8 0.145 
74.0 75.0 76.0 75.0 0.140 
0.75 0.0446 43.2 0.9501 43.1 0.0612 43.1 0.9388 42.9 0.145 
35.0 35.0 35.0 34.0 0.139 
1.0 0.0453 25.3 0.9503 25.5 0.0506 26.7 0.9429 26.4 0.141 
20.0 20.0 22.0 22.0 0.135 
1.25 0.0463 17.0 0.9508 17.0 0.0454 19.4 0.9558 19.5 0.138 
14.0 14.0 16.0 16.0 0.130 
1.5 0.0507 12.3 0.9506 12.2 0.0365 15.6 0.9652 15.7 0.133 
10.0 10.0 13.0 13.0 0.125 
1.75 0.0498 9.4 0.9508 9.4 0.0268 13.5 0.9723 13.5 0.130 
8.0 8.0 11.0 11.0 0.121 
2.0 0.0401 8.2 0.9631 8.2 0.0203 12.2 0.9817 12.3 0.127 
8.0 7.0 10.0 10.0 0.119 
Table 3 
Simulated values of the significance level and power for different values of 6.. The responses are 
drawn from N{0,1) under the null hypothesis and from N{0,1) and N(6.,1) under the alternative 
hypothesis. The nominal values of the significance level and power are a = 0.05 and 1 - {3 = 0.95. 
In the left half of the table, the results are based on a test where K{f) is calculated for N(0,1). In 
the right half of the table K{f) is estimated throughout each trial. The mean and median value of 
D,. are shown. The exact value of "Y(f) is 0.141. The estimation starts at n0=10 patients. Each 
result is based on N = 10000 simulations (except for 6. = 0.5 when N = 1000). 
K.{J) Kn 
Distribution & #pats 1-/3 #pats & #pats 1-/3 #pats Dn 
mean mean mean mean mean 
median median median median median 
Normal (0,1) 0.0453 25.3 0.9503 25.5 0.0530 26.8 0.9492 27.0 0.141 
20.0 20.0 22.0 22.0 0.134 
95% N(0,1)+ 0.0502 26.3 0.9446 26.6 0.0516 29.7 0.9448 29.2 0.134 
5% N(0,3) 21.0 21.0 24.0 24.0 0.127 
90% N(0,1)+ 0.0593 27.1 0.9356 27.4 0.0436 32.3 0.9453 32.5 0.127 
10% N(0,3) 22.0 22.0 27.0 26.0 0.121 
80% N(0,1)+ 0.0806 28.8 0.9164 29.2 0.0519 39.7 0.9484 39.9 0.114 
20% N(0,3) 23.0 24.0 32.0 32.0 0.109 
95% N(0,1)+ 0.0542 26.3 0.9419 26.7 0.0517 30.3 0.9486 30.0 0.133 
5% N(0,4) 21.0 22.0 25.0 24.0 0.126 
Uniform 0.0552 25.9 0.9431 26.0 0.0560 28.4 0.9440 28.0 0.133 
(O,y'i2) 21.0 21.0 24.0 23.0 0.1_29 
Logistic 0.0366 24.4 0.9627 24.3 0.0468 24.5 0.9532 24.4 0.149 
(b = -../3/'rr) 20.0 20.0 20.0 20.0 0.142 
Cauchy 0.0458 25.7 0.9529 25.7 0.0238 31.1 0.9764 30.9 0.134 
(r=0.54427) 21.0 21.0 26.0 26.0 0.126 
Double exp 0.0250 22.3 0.9765 22.4 0.0378 21.3 0.9660 21.2 0.164 
(-\ = v'2) 18.0 18.0 17.0 17.0 0.154 
Negative exp 0.0182 19.5 0.9827 19.5 0.0289 17.5 0.9735 17.7 0.185 
(-\ = 1) 16.0 16.0 14.0 15.0 0.172 
Gamma 0.0285 22.3 0.9717 22.1 0.0418 20.9 0.9600 21.0 0.163 
(a= 1/.../2, d = 2) 18.0 18.0 17.0 17.0 0.155 
Table 4 
Simulated values of the significance level and power for different types of distributions. The nominal 
values are a = 0.05 and 1 - f3 = 0.95. In the left half of the table K.{f) is calculated under the 
normal distribution (K.{f) = 1/(2y'?J). In the right half of the table K.{J) is estimated throughout 
the trial. The estimation starts at n0 = 10 patients. In addition to the mean and median number 
of patients, the mean and median of Dn are shown. The alternative hypothesis is A. = 1. Each 
result is based on N = 10000 simulations. 
